BusinessRespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep ApneaBy Nasdaq OMXNov 30, 2017, 1:45 PM UTC
BusinessTrevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain MedicationsBy Nasdaq OMXJun 20, 2017, 8:01 PM UTC
BusinessRheumatology Leaders Oppose Sweeping Healthcare Cuts in Trump Administration BudgetBy Nasdaq OMXMay 23, 2017, 8:52 PM UTC
BusinessRheumatology Leaders Oppose Sweeping Healthcare Cuts in Trump Administration BudgetBy Nasdaq OMXMay 23, 2017, 8:52 PM UTC
BusinessAlzheimer’s Foundation of America’s Statement on Approval of FY 2017 Funding Increase for Alzheimer’s Disease ResearchBy Nasdaq OMXMay 4, 2017, 7:58 PM UTC
